Cancer and Metastasis Reviews

, Volume 10, Issue 2, pp 103–113 | Cite as

Cytogenetics of human malignant melanoma

  • Jeffrey M. Trent
Article

Abstract

There has been a tremendous recent resurgence of interest in examining chromosomal abnormalities in human cancers (particularly solid tumors). This interest has been stimulated by the molecular examination of recurring chromosome abnormalities, and the recognition that they may pinpoint the location of growth regulatory sequences (e.g. cellular oncogenes). This finding coupled with the clear recognition that specific chromosome abnormalities can also have important diagnostic and prognostic implications, have caused this avenue of research to expand at a significant rate. The following brief review will summarize the current state of knowledge regarding recurring chromosome abnormalities in human malignant melanoma. A discussion of chromosome changes in pre-malignant skin lesions, primary melanoma, and metastatic melanoma is described. Brief descriptions of the potential clinical utility, and biologic relevance of chromosome abnormalities in this disorder are also discussed.

Key words

cytogenetics malignant melanoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lee JAH: Etiology, epidemiology, and prognosis of melanoma and skin neoplasms. Current Opinion in Onc 2: 388–393, 1990Google Scholar
  2. 2.
    Mitelman F: Catalog of chromosome aberrations in cancer, 4th Edition. New York, Alan R. Liss (in press)Google Scholar
  3. 3.
    Mitelman F, Kaneko Y, Trent JM: Report of the committee on chromosome changes in neoplasia. Cytogenet and Cell Genet 55: 358–386, 1990Google Scholar
  4. 4.
    Jaspers NGJ, Roza-de Jongh EJM, Donselaar IG, VanVelzen-Tillemans JTM, vanHemel JO, Rumke P, van derKamp AWM: Sister chromatid exchanges, hyperdiploidy and chromosomal rearrangements studied in cells from melanoma-prone individuals belonging to families with the dysplastic nevus syndrome. Cancer Genet Cytogenet 24: 33–43, 1987Google Scholar
  5. 5.
    Caporaso N, Greene MH, Tsai S, Pickle LW, Mulvihill JJ: Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: Is dysplastic nevus syndrome a chromosome instability disorder? Cancer Genet Cytogenet 24: 299–314, 1987Google Scholar
  6. 6.
    Lynch HT, Fusaro RM, Danes BS, Kimberling WJ, Lynch JF: A review of hereditary malignant melanoma including biomarkers in familial atypical multiple mole melanoma syndrome. Cancer Genet Cytogenet 8: 325–358, 1983Google Scholar
  7. 7.
    Sanford KK, Tarone RE, Parshad R, Tucker MA, Greene MH, Jones GM: Hypersensitivity to G2 chromatid radiation damage in famillial dysplastic naevus syndrome. Lancet ii: 1111–1116, 1987Google Scholar
  8. 8.
    Cowan JM, Halaban R, Francke U: Cytogenetic anlysis of melanocytes from premalignant nevi and melanomas. J Natl Cancer Inst 80: 1159–1164, 1988Google Scholar
  9. 9.
    Parmiter AH, Balaban G, ClarkJr WH, Nowell PC: Possible involvement of the chromosome region 10q24->q26 in early stages of melanocytic neoplasia. Cancer Genet Cytogenet 30: 313–317, 1988Google Scholar
  10. 10.
    McDonagh AJG, Wright AL, Messenger AG: Dysplastic naevi in association with partial deletion of chromosome 11. Clinical and Exper Derm 15: 44–45, 1990Google Scholar
  11. 11.
    Trent J, Olson S, Lawn R: Chromosomal localization of human leukocyte, fibroblast and immune interferon genes by means of in situ hybridization. PNAS 79: 7809, 1982Google Scholar
  12. 12.
    Becher R, Gibas Z, Karakousis C, Sandberg AA: Nonrandom chromosome changes in malignant melanoma. Cancer Res 43: 5010–5016, 1983Google Scholar
  13. 13.
    Trent JM, Rosenfeld SB, Meyskens FL: Chromosome 6q involvement in human malignant melanoma. Cancer Genet Cytogenet 9: 177–180, 1983Google Scholar
  14. 14.
    Pathak S, Drwinga HL, Hsu TC: Involvement of chromosome 6 rearrangements in human malignant melanoma cell lines. Cytogenet Cell Genet 36: 573–579, 1983Google Scholar
  15. 15.
    Balaban G, Herlyn M, Guerry D, Bartolo R, Koprowski H, Clark WH, Nowell PC: Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 11: 429–439, 1984Google Scholar
  16. 16.
    Pedersen MI, Bennett JW, Wang N: Nonrandom chromosome structural aberrations and oncogene loci in human malignant melanoma. Cancer Genet Cytogenet 20: 11–27, 1986Google Scholar
  17. 17.
    Cowan JM, Halaban R, Lane AT, Francke U: The involvement of 6p in melanoma. Cancer Genet Cytogenet 20: 255, 1986Google Scholar
  18. 18.
    Parmiter AH, Balaban G, Herlyn M, Clark WH, Nowell PC: A t(1;19) chromosome translocation in three cases of human malignant melanoma. Cancer Res 46: 1526–1529, 1986Google Scholar
  19. 19.
    Trent JM, Thompson FH, Meyskens FL: Cytogenetics of melanoma. In: TSlaga (ed.) Skin Cancer Biology. Raven Press, New York, pp 165–186, 1989Google Scholar
  20. 20.
    Trent JM, Thompson FH, MeyskensJr FL: Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma. Cancer Res 49: 420–423, 1989Google Scholar
  21. 21.
    Grammatico P, LoRe ML, Scarpa S, Modesti A, DelPorto G: Human malignant melanoma. Significance of chromosomal abnormalities. Cancer Genet Cytogenet 48: 237–242, 1990Google Scholar
  22. 22.
    Limon J, Dal Cin P, Sait SNJ, Karakousis C, Sandberg AA: Chromosome changes in metastatic human melanoma. Cancer Genet Cytogenet 30: 201–211, 1988Google Scholar
  23. 23.
    Heim S, Mandahl N, Arheden K, Giovannella BC, Yim SO, StehlinJr JS, Mitelman F: Multiple karyotypic abnormalities, including structural rearrangements of 11p, in cell lines from malignant melanomas. Cancer Genet Cytogenet 35: 5–20, 1988Google Scholar
  24. 24.
    Kacker RK, Giovanella BC, Pathak S: Consistent karyotypic abnormalities in human malignant melanomas. Anti-cancer Res 10: 859–872, 1990Google Scholar
  25. 25.
    Millikin D, Meese E, Witowski C, Meltzer P, Trent JM: Loss of constitutional heterozygosity for loci on chromosome 6q in human malignant melanoma. Cancer Res, in press, 1991Google Scholar
  26. 26.
    Koprowski H, Herlyn M, Balaban G, Parmiter A, Ross A, Nowell P: Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma. Somatic Cell and Mol Genet 11: 297–302, 1985Google Scholar
  27. 27.
    Fearon ER, Vogelstein B, Feinberg AP: Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours. Nature 309: 176–178, 1984bGoogle Scholar
  28. 28.
    Dracopoli NC, Houghton AN, Old LJ: Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity. Proc Natl Acad Sci 82: 1470–1474, 1985Google Scholar
  29. 29.
    Nordenskjold M, Werelius B, Ringborg U: Allele losses in malignant melanoma reflect random events. Anticancer Res 10: 883–886, 1990Google Scholar
  30. 30.
    Muir PD, Gunz FW: A cytogenetic study of eight human melanoma cell cell lines. Pathology 11: 597–606, 1979Google Scholar
  31. 31.
    Kakati S, Song SY, Sandberg AA: Chromosomes and causation of human cancer and leukemia. XXII, Karyotypic changes in malignant melanoma. Cancer 40: 1173–1181, 1977Google Scholar
  32. 32.
    Atkin NB, Baker MC: A metastatic malignant melanoma with 24 chromocomes. Hum Genet 58: 217–219, 1981aGoogle Scholar
  33. 33.
    Ferguson-Smith MA: The sites of nucleolus formation in human pachytene chromosomes. Cytogenet 3: 124–134, 1964Google Scholar
  34. 34.
    Goodpasture C, Bloom SE: Visualization of nucleolar organizing regions in mammalian chromosomes using silver stain. Chromosoma 53: 37–50, 1975Google Scholar
  35. 35.
    Howell WM, Denton TE, Diamond JR: Differential staining of human acrocentric chromosomes. Experientia 31: 260–262, 1975Google Scholar
  36. 36.
    Trent JM, Carlin DA, Davis JR: Expression of silver-stained nucleolar organizing regions (Ag-NORs) in human cancer. Cytogenet Cell Genet 30: 31–38, 1981Google Scholar
  37. 37.
    Howat AJ, Wright AL, Cotton DWK, Reeve S, Bleehen SS: AgNORs in benign, dysplastic, and malignant melanocytic skin lesions. American Jr Derm 12(2): 156–161, 1990Google Scholar
  38. 38.
    Crocker J, Skibeck N: Nucleolar organiser region-associated proteins in cutaneous melanotic lesions: a quantitative study. J Clin Pathol 40: 885–889, 1987Google Scholar
  39. 39.
    Howat AJ, Giri DD, Cotton DWK, Slater DN: Nucleolar organiser regions in Spitz nevi and malignant melanomas. Cancer 63: 474–478, 1989Google Scholar
  40. 40.
    Egan M, Crocker J: Nucleolar organiser regions in cutaneous tumours. J Pathol 154: 247–253, 1988Google Scholar
  41. 41.
    Trent JM, Meyskens FL, Salmon SI, Ryschon K, Leong SPL, Davis JR, McGee DL: Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. N Engl J Med 322: 1508–1511, 1990Google Scholar
  42. 42.
    KnudsonJr AG, Hethcote HW, Brown BW: Mutation of childhood cancer: A probabilistic model for the incidence of retinoblastoma. Proc Natl Acad Sci USA 72: 5116–5120, 1975Google Scholar
  43. 43.
    Friend SH, Drya TP, Weinberg RA: Oncogenes and tumor-suppressing genes. N Engl J Med 318: 618, 1988Google Scholar
  44. 44.
    Trent JM, Standbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowski CM, Nagle RB: Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247: 568–571, 1990Google Scholar
  45. 45.
    Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R: Allelotype of colorectal carcinomas. Science 244: 207–211, 1989Google Scholar
  46. 46.
    Bale SJ, Dracopoli NC, Tucker MA, ClarkJr WH, Fraser MC, Stanger BZ, Green P, Donis-Keller H, Housman DE, Greene MH: Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 320: 1367–1372, 1989Google Scholar
  47. 47.
    Dracopoli NC, Harnett Bale SJ et al.: Loss of alleles from distal chromosome 1p occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86: 4614–4618, 1989Google Scholar

Copyright information

© Kluwer Academic Publishers 1991

Authors and Affiliations

  • Jeffrey M. Trent
    • 1
  1. 1.Department of Radiation Oncology and Human GeneticsUniversity of MichiganAnn ArborUSA

Personalised recommendations